Abstract
Background Recent studies have identified important social inequalities in SARS-CoV-2 infection and related COVID-19 outcomes in the Belgian population. The aim of our study was to investigate the sociodemographic and socioeconomic characteristics associated with the uptake of COVID-19 vaccine in Belgium.
Methods We conducted a cross-sectional analysis of the uptake of a first COVID-19 vaccine dose among 5,342,110 adults (≥18 years) in Belgium from December 28th 2020 (official starting date of the vaccination campaign) until August 31st 2021. We integrated data from four national data sources: the Belgian vaccine register (vaccination status), COVID-19 Healthdata (laboratory test results), DEMOBEL (sociodemographic/socioeconomic data), and the Common Base Registry for HealthCare Actors (individuals licensed to practice a healthcare profession in Belgium). We used multivariable logistic regression analysis for identifying characteristics associated with not having obtained a first COVID-19 vaccine dose in Belgium and for each of its three regions (Flanders, Brussels, and Wallonia).
Results During the study period, 10% (536,716/5,342,110) of the Belgian adult population included in our study sample was not vaccinated with a first COVID-19 vaccine dose. A lower COVID-19 vaccine uptake was found among young individuals, men, migrants, single parents, one-person households, and disadvantaged socioeconomic groups (with lower levels of income and education, unemployed). Overall, the sociodemographic and socioeconomic disparities were comparable for all regions.
Conclusions The identification of sociodemographic and socioeconomic disparities in COVID-19 vaccination uptake is critical to develop strategies guaranteeing a more equitable vaccination coverage of the Belgian adult population.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
https://clinicaltrials.gov/ct2/show/NCT05373420
Funding Statement
This study was supported by the Belgian Federal Authorities through funding for the LINK-VACC project on vaccine surveillance. In addition, Belgian Science Policy Office (BELSPO) funded this research within the BRAIN-be 2.0 framework supporting pillar 3 Federal societal challenges (grant number B2/202/P3/HELICON).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Medical Ethics committee from the Vrije Universiteit of Brussels gave ethical approval for this research project on 3 February 2021 (B.U.N 1432020000371). This research project also obtained authorization from the Information Security Committee (ISC) Social Security and Health (reference number: IVC/KSZG/21/034). As confirmed by sections 23 and 24 of the Guidelines 03/2020 on the processing of data concerning health for the purpose of scientific research in the context of the COVID-19 outbreak of the European Data Protection Board (V1.0 of 21 April 2020), this survey falls under Article 6,section 1(e) and Article 9,section 2(i) of the General Data Protection Regulation (GDPR). In appliance with these GDPR legal grounds of data processing, no informed consent had to be signed by the patients.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data used in this study are pseudonymised individual data obtained from several national registers hosted by Healthdata.be, an independent institution within Sciensano aiming to bring together all the data currently stored in multiple health registers on a single web-based platform. Due to the General Data Protection Regulation (GDPR) legislations in Belgium, these data are not publicly available. Data request must be addressed to the Information Security Committee (ISC).
List of abbreviations
- SARS-CoV-2
- Severe Acute Respiratory Syndrome Coronavirus 2
- COVID-19
- Coronavirus disease 2019
- SD
- Sociodemographic
- SE
- Socioeconomic
- Statbel
- Statistics Belgium
- CoBRHA
- Common Base Registry for HealthCare Actors
- ISCED
- International Standard Classification of Education.
